Increased Hepatic ACE2 Expression in NAFL and Diabetes—A Risk for COVID-19 Patients?-Reference-Cited by-同舟云学术

Increased Hepatic ACE2 Expression in NAFL and Diabetes—A Risk for COVID-19 Patients?

Author:

Soldo Jelena¹^ORCID,Heni Martin¹²³⁴^ORCID,Königsrainer Alfred⁵,Häring Hans-Ulrich³⁴,Birkenfeld Andreas L.²³⁴,Peter Andreas¹³⁴

Affiliation:

1. Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany

2. Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany

3. Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany

4. German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany

5. Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference5 articles.

3. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein;Walls,2020

5. Multiorgan and renal tropism of SARS-CoV-2;Puelles;N Engl J Med

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献